Somatostatin receptors 3, 4 and 5 play important roles in gallbladder cancer

Published on Friday, 04 July 2014


Expression changes of somatostatin receptor subtypes (SSTRs) including SSTR1, SSTR2, SSTR3, SSTR4 and SSTR5 in the development of gallbladder cancer were assessed with attention to relationships with clinical pathological characteristics.

SSTRs in 29 gallbladder cancer and 25 normal gallbladder tissue specimens were examined by immunohistochemical staining. Differences between SSTRs expressions and clinical pathological parameters were analyzed by chi-square test.

The five subtypes of SSTR were all expressed in gallbladder cancer tissues and SSTR3 presented the highest expression.

SSTR5 expression was increased significantly in gallbladder cancer (P < 0.05) compared with that in normal gallbladder tissue.

SSTR3 expression in highly and moderately differentiated gallbladder cancer was significantly higher than that in poorly differentiated lesions (P < 0.05).

SSTR4 expression was lower in gallbladder cancer with lymph node metastasis than that in gallbladder cancer without lymph node metastasis (P < 0.05).

Therfore, these results indicated that SSRT5, SSTR3 and SSTR4 may play important roles in the formation and development of gallbladder cancer.



About this publication.


See also Somatostatin in oncology, the overlooked evidences.